Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Researchers first identified it decades ago and later discovered that levels tend to decline with age
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
Liraglutide, having been used clinically for over 10 years in China and benefiting from physicians extensive experience in dose adjustment and managing adverse reactions, may influence the short-term cost-effectiveness of oral semaglutide [36]
The medication occupies GLP-1 receptors to suppress appetite, manage blood sugar levels, and promote weight loss
US$ 25.05
US$ 29.31
US$ 20.00
US$ 29.73
US$ 26.80
US$ 20.88
US$ 27.91
US$ 28.35
US$ 24.29
US$ 26.84
